Meerecompany
1 known investors
Korean technology manufacturer building the Revo-i surgical robot system, 3D sensor solutions and display/semiconductor equipment.
Also known as Meere Company Β· λ―Έλμ»΄νΌλ
Investors Β· 1
Company profile
researched Aug 2026Meerecompany is a South Korean technology manufacturer, founded in 1984 and based in Seoul, that operates across three business areas: surgical robotics, sensors and industrial equipment. Its surgical robotics line centres on Revo-i, a laparoscopic robotic surgical system, together with Revo-sim, a virtual-reality training simulator; the company describes Revo-i as the first surgical robot developed in Korea and the second in the world, and positions it as a cost-effective platform sold alongside instruments, maintenance and support services rather than as a standalone device.
The sensor business develops and supplies 3D recognition camera and sensor solution technologies, marketed under the Cube Eye name, for consumer electronics, surveillance, retail intelligence, automotive, robotics, medical, AR/VR and 3D scanning and mapping applications. The company states it handles customised product development and supply with internalised R&D and mass-production capability. The industrial equipment business serves display, semiconductor, LED, automotive, chemical and optics customers, and the company describes itself as the first in the display industry in Korea to localise manufacturing equipment and as holding integrated processing, inspection and laser technology, with its Edge Grinder product cited as holding the leading global market share.
The company reports more than 250 patents, R&D personnel representing more than 50% of staff, and annual R&D investment of over KRW 10 billion, alongside corporate figures of KRW 673.0 billion in sales, KRW 333.0 billion in exports, KRW 156.0 billion in R&D investment and 365 employees.
Business model
Meerecompany manufactures and sells capital equipment and systems across three lines: robotic surgical systems and training simulators for hospitals, sensor and 3D camera solutions supplied to industrial customers on a customised development basis, and display, semiconductor and related manufacturing/inspection equipment. For surgical robotics the company states it provides a total robotic surgery program including instruments, maintenance and an end-to-end support team, with cost-per-case economics aimed at hospital financial sustainability.
Traction
Reported metrics include KRW 673.0 billion in sales, KRW 333.0 billion in exports, 365 employees and more than 250 patents. Revo-i installations and clinical milestones reported include 500 surgical cases at Korea Cancer Center Hospital, 350 cases at Queen's Park Women's Hospital, 100 cases at Severance Hospital, first hepatectomy and lymphadenectomy, first robotic parathyroidectomy, first robotic ureteral reconstruction and first transoral robotic surgery using the system, plus a Revo-sim installation at Seoul National University Bundang Hospital. Korean press reported a second consecutive profitable quarter in August 2026 attributed to the semiconductor and surgical robot businesses.
Latest developments
Company news in August 2026 covered a second consecutive quarterly profit attributed to the semiconductor and surgical robot businesses, published clinical experience with Revo-i gastrectomy in gastric cancer, and Korean coverage of surgical robot reimbursement policy. Recent product and commercial news includes a second Revo-i export to Mongolia, recognition of Revo-i as an innovative product by the Korean Ministry of Trade, Industry and Resources, the opening of an official Revo-i robotic surgery centre in Tunisia, medical device approval in the Philippines, and MOUs with the Korea Institute of Radiological and Medical Sciences, the Mongolian Center for Health Development and the Korean Society of Endourology and Robotics.
βΈFull profile β market position, technology, go-to-market, geography, history
Market position
The company states it was the first in Korea to commercialise a surgical robot and the second worldwide, and that its Edge Grinder holds first place in global market share. It describes itself as playing a leading role in the Korean display equipment, 3D camera and surgical robot industries.
Meerecompany positions Revo-i as an affordable alternative in robotic surgery, emphasising lower cost per case inclusive of instruments and maintenance and full operating-room support, and states it is the only company in its industry to combine processing, inspection and laser technologies in a single integrated offering.
Technology
Core technologies include the Revo-i robotic surgical system, which the company describes as offering high-resolution 3D visualisation, 12 degrees of freedom of motion, intuitive master control, and virtual reality simulation training through Revo-sim; 3D recognition camera and sensor solutions (Cube Eye); and integrated processing, inspection and laser technology for display and semiconductor manufacturing equipment. Patents listed by the company cover surgical robot master gripper and master arm structures and control methods, and diffractive optical elements and optical systems.
Go-to-market
The surgical robot business is sold through direct supply agreements and MOUs with hospitals and health institutions in Korea and internationally, supported by clinical proctoring, symposia, appointed global ambassadors and trainers, and installation of training simulators at teaching hospitals. Regulatory approvals in individual markets, such as the Philippines, support export sales.
Hospitals and surgical teams performing minimally invasive procedures; manufacturers in display, semiconductor, LED, automotive, chemical and optics industries; and companies in consumer electronics, surveillance, retail, robotics, medical, AR/VR and 3D scanning markets requiring sensor solutions.
Geography
Headquartered at 3F 155 Songpa-daero, Songpa-gu, Seoul, South Korea, with a Korean-, English- and Chinese-language web presence. Revo-i deployments and agreements are reported in Korea and in export markets including Mongolia, Tunisia, Paraguay, Morocco, Uzbekistan and the Philippines. Reported exports total KRW 333.0 billion.
History
Meerecompany was founded in 1984 and established affiliated corporate research centres across its business sectors. In 2000 it localised the Edge Grinder, a display manufacturing tool previously dependent on imports, and states it has since held the largest global market share in that product over 17 years. It developed a surgical robot prototype in 2008 and commercialised the Revo-i system, which the company variously dates to 2017 and 2018. In 2014 it developed the Cube Eye 3D recognition camera. In 2016 it was selected as a World Class 300 company, and it has received the Industrial Service Medal of Honor.
Compiled by commissioned research from 8 cited public sources β announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed β not independently audited.
Timeline Β· 12
launches, deals, and filingsKorean trade press (Robot Newspaper) reported that Meerecompany posted a second consecutive quarter of profit, attributed to the establishment of its semiconductor and surgical robot businesses.
The Revo-i system was designated an innovative product by the Korean Ministry of Trade, Industry and Resources.
Following a supply agreement with Tunisia, an official Revo-i robotic surgery centre was opened, with Charles Nicolle Hospital reported as leading robotic surgery in the country.
The company signed a contract to supply Revo-i to Paraguay and reported first surgeries there, and supplied the system to hospitals in Morocco and Uzbekistan.
The company announced a second export of the Revo-i system to Mongolia; it also signed an MOU with the Mongolian Center for Health Development.
Meerecompany signed a memorandum of understanding with the Korean Society of Endourology and Robotics; it also signed a business agreement with the Robot Endoscopy Surgery Center at Severance Hospital and an MOU with KIRAMS.
The Revo-i surgical robot obtained medical device approval in the Philippines.
Meerecompany commercialised Revo-i, described as the first surgical robot developed in Korea and the second in the world. The company's About Us page dates commercialisation to 2017; a company profile page states 2018.
The company was designated a World Class 300 company and states it also received the Industrial Service Medal of Honor.
Meerecompany developed a 3D recognition camera branded Cube Eye, entering the sensor solutions market.
The company successfully developed its first surgical robot prototype, the basis for the later Revo-i system.
Meerecompany states it was the first in Korea to localise the Edge Grinder, a display manufacturing tool that had been fully dependent on imports, and has since held the largest global market share for the product.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
βΈResearch sources Β· 8
primary sources listed
- Meerecompanymeerecompany.com Β· web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Meerecompany do?
- Korean technology manufacturer building the Revo-i surgical robot system, 3D sensor solutions and display/semiconductor equipment.
- Who are Meerecompany's investors?
- Meerecompany's investors include Kiwoom Investment.